Citation: | Advances in Selective COX-2 Inhibitors[J]. Journal of China Pharmaceutical University, 2003, (3): 1-6. |
[1] | DU Te, CHEN Jing, SHEN Xu. Research advances in susceptibility genes of non-alcoholic fatty liver disease and its association with type 2 diabetes[J]. Journal of China Pharmaceutical University, 2018, 49(5): 537-544. DOI: 10.11665/j.issn.1000-5048.20180504 |
[2] | XIN Minhang, ZHANG Sanqi. Advances in PI3Kδ selective inhibitors[J]. Journal of China Pharmaceutical University, 2016, 47(5): 503-510. DOI: 10.11665/j.issn.1000-5048.20160501 |
[3] | NIU Jiaqi, ZHU Yong, ZHAO Shuang, TANG Xiaotian, ZHANG Zhimin, LU Tao. Advances in histone deacetylase 8 selective inhibitors[J]. Journal of China Pharmaceutical University, 2016, 47(3): 251-258. DOI: 10.11665/j.issn.1000-5048.20160301 |
[4] | ZHAO Heng-guang, LUO Fu-ling. Effects of tetrandrine on COX-2/PGE2,iNOS/NO expression in LPS-stimulated RAW264.7 cells[J]. Journal of China Pharmaceutical University, 2011, 42(2): 141-144. |
[5] | Cloning of D-hydantoinaseGene from Pseudomonas and Its Expression in E.coli[J]. Journal of China Pharmaceutical University, 2001, (3): 69-72. |
[6] | The High Expression of hGRF Gene[J]. Journal of China Pharmaceutical University, 1999, (6): 68-72. |
[7] | Synthesis Cloning and Fusion Expression of the Human Parathyroid Hormone N terminus 34 Peptide Gene[J]. Journal of China Pharmaceutical University, 1999, (3): 56-59. |
[8] | Molecular Cloning and Expression of Tryptophanase Gene of Escherichia coli[J]. Journal of China Pharmaceutical University, 1999, (2): 61-64. |
[9] | High Expression of Hepatitis B Core Gene in E. coli[J]. Journal of China Pharmaceutical University, 1993, (1): 60-62. |
[10] | High Expression of Hepatitis B e Gene in E. coli[J]. Journal of China Pharmaceutical University, 1992, (5): 290-293. |